Steven Cohen Procept Bio Robotics Corp Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$26.64 - $39.74 $2.88 Million - $4.3 Million	-108,294 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $4.2 Million - $5.07 Million	108,294 New	108,294 $4.5 Million
Q4 2021 Feb 14, 2022	SELL	$24.6 - $46.29 $369,000 - $694,350	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.91 - $41.94 $538,650 - $629,100	15,000 New	15,000 $572,000

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.17B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.